Contribute to AFPE

Why Give?

AFPE relies on annual contributions from individuals and organizations to help achieve our mission to support the education of outstanding students in the pharmaceutical sciences. AFPE Fellowship award recipients express pride and accomplishment, encouraged by the fact that their possibilities have been recognized.

In 2016, AFPE had a record number of applicants from over forty prestigious schools of pharmacy across the country.This year, AFPE received 246 applications. However, our financial limitations required us to cap funding to fifty-four awards. As we continue to evolve and expand, our goal is to fund as many of the qualified applicants as possible. We hope you will join us in working to fund the next generation of pharmaceutical science researchers!

AFPE welcomes individual gifts of all amounts, as well as corporate gifts. If you are interested in working with your company or university to create a matching gift, or in more information about tribute, memorial, estate, or stock gifts, please contact Sarah Devereaux-Hardimon, Development Associate.

We are also looking for subject area experts in the fields of pharmaceutical science and chemistry to make the most accurate assessments of application materials submitted for each award cycle. We are always looking for volunteers willing to share their expertise. If you are interested in becoming an expert reviewer, please contact Sarah Devereaux- Hardimon to assist in our mission of investing in future leaders in pharmaceutical science research and education.

Donation Levels

$100,0001942 Founder’s Circle
$75,000Cornerstone Circle
$50,000Legacy Circle
$25,000 – Chairman’s Circle


$2,000President’s Club
$750Distinguished Contributor

$500Dean’s List
$250Friend of AFPE
$150AFPE Donor
$100Annual Supporter

Ways to Donate

Send in the mail.

Tribute, Memorial, Stock, and Estate Gifts.

In-Kind Donations, Cooperative Marketing Opportunities, and Special Events.

If you have any questions regarding how best to donate to AFPE, please do not hesitate to contact Ellen Woods to discuss the many opportunities and ways you can help invest in the future leaders in Pharmaceutical Science Research and Education.

Research Areas of AFPE Fellows

  • Acute Coronary Syndrome
  • Acute Myocardial Infarction
  • Arryhthmia
  • Atrial Fibrillation
  • Cardiovascular Disease
  • Congestive Heart Failure
  • COPD
  • Delta Storage Pool Deficiencies; Thrombocytopenia
  • Heart Failure
  • Ischemic Stroke
  • Lung Disease
  • Thrombosis
  • Diabetes
  • Hyperlipidemia
  • Obesity
  • Drug Resistant M. Tuberculosis
  • Hepatitis
  • HIV/HIV-1
  • HPV
  • Immunology
  • Influenza
  • Methicillin Resistant Staphylococcus Aureus (MRSA)
  • Microbial Pathogens
  • Respiratory Syncytial Virus (RSV) in Infants
  • Vaccinable Diseases
  • Alzheimer’s Disease
  • Epilepsy
  • Ischemic and Hemorrhagic Stroke
  • Muscular Dystrophy
  • Neurotrauma
  • Parkinson’s Disease
  • Brain Tumor (Glioblastoma Multiforme)
  • Cancer Therapy and Drug Resistance
  • Colorectal Adenosarcoma
  • Liver Cancer
  • Ovarian Cancer
  • Pancreatic Cancer
  • Prostate Cancer
  • Sarcomas
  • Asthma
  • Behavioral Research
  • Drug Induced Liver Injury
  • Genitourinary System Dysfunction
  • Herb-Drug Interactions
  • Intrahepatic Cholestasis of Pregnancy (ICP)
  • Immunotherapy
  • Infertility
  • Medication Adherence
  • Mental Illness
  • Pediatric Cardiac Arrest
  • Pompe Disease (Glycogen Storage Disease Type II)
  • Transitions of Care in Older Adults
  • Vitamin Supplementation/Dosage Evaluation

Value of the Pharmaceutical Sciences

Pharmaceutical scientists trained at U.S. schools and colleges of pharmacy are working on breakthrough technologies made possible by combinatorial chemistry, in vitro biopharmaceutical techniques, analytical technologies, bio-materials, and gene transfers-gene therapies such as:

  • Accelerated chemical synthesis and biological screening of millions of compounds to identify as well as optimize structurally novel drug candidates
  • Molecular-based assays using cloned enzymes to predict how the body will metabolize a promising drug candidate before large investments are made in development and animal testing
  • Using cloned metabolizing enzymes or human tissue to analyze and predict toxicity problems and other associated costs prior to a drug’s clinical investigation
  • Implantation or injection of large molecules that are biocompatible over long periods of time to allow delivery of medication at controlled rates over the full course of therapy
  • Providing a gene therapy in a stable form, targeted to a specific site, in a safely administered dosage system

Fundamental changes in drug discovery and development brought about by these new technologies are impacting graduate education in the pharmaceutical sciences both in the graduate curriculum and the research environment. The pharmaceutical sciences disciplines at U.S. college of pharmacy graduate schools include:

The study of drug therapy outcomes in patients with emphasis on factors & mechanisms determining therapy outcomes; the study of genetic & non-genetic factors in the variability of drug response; the study of human pharmacology & therapeutics to improve safe, effective & economical use of medications by patients; and the optimization of drug therapy through generation, integration, & translation of scientific knowledge between the bench and the bedside.

The economic analysis of pharmaceuticals, pharmaco-economic protocol development, pharmaceutical outcomes research, disease management protocols and processes, and management of pharmacy systems and organization.

The design and synthesis of chemical/organic compounds with biological activity and potential use in treatment of disease

The analysis, biosynthesis, production, metabolism, and mechanisms of action of pharmaceutically important plants, animals, and microbes

The design, fabrication, and evaluation of advanced drug delivery and advanced drug level management systems

The use of genetic, molecular, cellular, organ system, and whole animal techniques to examine mechanisms and consequences of drug interactions with living systems

The analysis of adverse effects of new biologically active compounds on living systems, such as tissue injury, reproductive failure, immunosuppression, and cancer